DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 2.14% to $10.52 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.19% to 25,067.80 and Dow Jones Industrial Average falling 1.13% to 48,941.90.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 48.83% below its 52-week high of $20.56, which the company reached on October 20th.
The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 8.00% to $7.56, Fortress Biotech Inc. (FBIO) rose 2.15% to $2.38, and Viking Therapeutics Inc. (VKTX) rose 5.87% to $31.76.
Trading volume (282,208) eclipsed its 50-day average volume of 246,695.
Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 04, 2026 17:21 ET (21:21 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments